Optimal transport weights for causal inference
用于因果推断的最优传输权重AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要以分布平衡权重估计因果效应,并讨论潜在结局插补。
用于因果推断的最优传输权重AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Imbalance in covariate distributions leads to biased estimates of causal effects. Weighting methods attempt to correct this imbalance but rely on specifying models for the treatment assignment mechanism, which is unknown in observational studies. This leaves researchers to choose the proper weighting method and the appropriate covariate functions for these models without knowing the correct combination to achieve distributional balance. In response to these difficulties, we propose a nonparametric generalization of several other weighting schemes found in the literature: Causal Optimal Transport. This new method directly targets distributional balance by minimizing optimal transport distances between treatment and control groups or, more generally, between any source and target population. Our approach is semiparametrically efficient and model-free but can also incorporate moments or any other important functions of covariates that a researcher desires to balance. Moreover, our method can provide nonparametric estimate the conditional mean outcome function and we give rates for the convergence of this estimator. Moreover, we show how this method can provide nonparametric imputations of the missing potential outcomes and give rates of convergence for this estimator. We find that Causal Optimal Transport outperforms competitor methods when both the propensity score and outcome models are misspecified, indicating it is a robust alternative to common weighting methods. Finally, we demonstrate the utility of our method in an external control trial examining the effect of misoprostol versus oxytocin for the treatment of post-partum hemorrhage.